Leaflet ATAZANAVIR ZENTIVA 150mg capsules

Product code:
W64332002
Quantity:
60
Indicated for:
HIV-1 infection
Route of administration:
oral
Substance:
atazanavir (protease inhibitor)
ATC
J05AE08 — Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors

Precautions:

Breastfeeding warning

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Pregnancy warning

Use during pregnancy only on medical advice.

Atazanavir is an antiretroviral medication used for the treatment of human immunodeficiency virus (HIV) infection. It belongs to the class of protease inhibitors and works by blocking the HIV protease enzyme, which is essential for viral replication. By inhibiting this enzyme, atazanavir reduces viral load and helps maintain immune system function.

Atazanavir is administered orally, usually once daily, in combination with other antiretroviral medications as part of highly active antiretroviral therapy (HAART). It is recommended to be taken with food to improve absorption.

Common side effects include nausea, jaundice, headaches, abdominal pain, and skin rashes. In rare cases, severe adverse reactions such as liver impairment, severe hyperbilirubinemia, or allergic reactions may occur.

Patients taking atazanavir should undergo regular monitoring for liver function and bilirubin levels. Additionally, the medication may interact with other drugs, requiring caution. Atazanavir is an important component of HIV treatment, contributing to improved quality of life for patients living with the virus.

General data about ATAZANAVIR ZENTIVA 150mg

Substance:
atazanavir
Date of latest medicines list:
01-01-2023
Product code:
W64332002
Concentration:
150mg
Pharmaceutical form:
capsules
Quantity:
60
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
ZENTIVA, K.S. - REPUBLICA CEHA
Holder:
ZENTIVA, K.S. - REPUBLICA CEHA
Number:
10522/2018/02
Shelf life:
2 years

Pharmaceutical forms available for atazanavir

Concentrations available for atazanavir

  • 100mg
  • 150mg
  • 200mg
  • 300mg
  • 50mg/1.5g

Combinations with other substances